SlideShare a Scribd company logo
Dr/Omnia Sarhan 1
PHARMACOKINETICS
Lecture 5
Dr/Omnia Sarhan
‫الكليـــــــــــــة‬ ‫رؤيــــــــــــة‬
‫الكليــــــــــــة‬ ‫رســـــــــــــــالة‬
‫الريادة‬
ً
‫محليا‬
ً
‫واقليميا‬
ً
‫ودوليا‬
‫لالرتقاء‬
‫بصحة‬
‫االنسان‬
‫من‬
‫خالل‬
‫استخدا‬
‫م‬
‫االبتكارات‬
‫فى‬
‫مجال‬
‫التعليم‬
‫والبحوث‬
‫العلمية‬
‫والممارسات‬
‫التطبيقية‬
.
‫توفير‬
‫أفضل‬
‫الممارسات‬
‫في‬
‫مجال‬
‫التعليم‬
‫والتعلم‬
‫والتدريب‬
‫وإستمرارية‬
‫خ‬
‫لق‬
‫فرص‬
‫للطالب‬
‫والخريجين‬
‫بإبتكار‬
‫ونشر‬
‫وتطبيق‬
‫المعرفة‬
‫الحديثة‬
‫المرتكزة‬
‫على‬
‫البحوث‬
‫والتطبيقات‬
‫في‬
‫العلوم‬
‫الصيدلية‬
‫واإلكلينيكية‬
‫واإلجتماعية‬
‫للنهوض‬
‫بال‬
‫صحة‬
Dr/Omnia Sarhan
3
Upon successful completion of this course the student should be able to;
• Describe the physicochemical and physiological factors that influence the
absorption of drugs
from extra and intravascular routs of administration, their distribution within the
body, and their
routes and mechanisms of elimination
• Explain how dose, bioavailability, rate of absorption, apparent volume of
distribution, total
clearance, and elimination half-life affect the plasma concentrations of a drug after
administration of single oral or single IV bolus dose
• Describe the factors which determine the time-course of systemic accumulation of
a drug
administered by multiple oral, multiple IV bolus and continuous infusion doses
• Differentiate between linear and non-linear pharmacokinetic models
Introduction
Dr/Omnia Sarhan 4
I- Logarithm
The logarithm of a number is the exponent or power to which a given base number must be raised to equal
that number. Thus, the logarithm of Y to the base, b, equals X, or log b (Y) = X. The logarithm of 0 and all
negative numbers is undefined or nonexistent. The logarithm of 1 is 0 and of numbers <1 is negative in all
systems.
The relationships between common and natural logarithms are the following:
a. log Y = ln Y/ln 10 = ln Y/2.303
b. ln Y = ln 10 × log Y = 2.303 × log Y
Introduction
Dr/Omnia Sarhan 5
II- Calculus
1- Differential Calculus
Pharmacokinetics is the study of the rate of drug absorption and disposition in the body. Thus differential calculus
is an important stepping stone in the development of many of the equations used.
Differential calculus is involved with the study of rates of processes. The calculus part comes in when we look at
these processes in detail, that is, during small time intervals. We may say that at time zero a patient has a concentration
of 25 mg/l of a drug in plasma and at time 24 hours the concentration is 5 mg/l. That may be interesting in itself, but it
doesn't give us any idea of the concentration between 0 and 24 hours, or after 24 hours. Using differential calculus we
are able to develop equations to look at the process during the small time intervals that make up the total time interval
of 0 to 24 hours.
Introduction
Dr/Omnia Sarhan 6
In many cases the rate of elimination of a drug can
be described as being dependent on or proportional to
the amount of drug remaining to be eliminated. That is,
the process obeys first order kinetics. This can illustrated
by the opposite Figure.
This can be described mathematically using equation:
Where:
k is a proportionality constant (rate constant)
X is the amount remaining to be eliminated.
Introduction
Dr/Omnia Sarhan 7
Note: the use of the symbol 'd' to represent a very small increment in X or t. Thus dX/dt represents the slope of the
line (or rate of change) over a small region of the curved line. When data are collected at discrete times such as 4 and 6
hours the larger change in X and t can be represented by ΔX/Δt
Integration of the above equation (and other differential equations) provides the following integrated equations:
2- Integral Calculus
Differentiation is the reverse of integration. With differentiation breaking a process down to look at the
instantaneous process, integration sums up the information from small time intervals to give a total result over a larger
time period.
Introduction
Dr/Omnia Sarhan 8
First: How writing differential equations?
Rate processes in the field of pharmacokinetics are usually limited to first order, zero order and occasionally
Michaelis-Menten kinetics. Linear pharmacokinetic systems consist of first order disposition processes and bolus
doses, first order or zero order absorption rate processes. These rate processes can be described mathematically.
First Order Equation
Each first order rate process is described by a first order rate constant (k1) and the amount or concentration
remaining to be transferred (X1).
Zero Order Equation
Introduction
Dr/Omnia Sarhan 9
Zero order rate processes are described by the rate constant alone.
Michaelis Menten Equation
The Michaelis Menten process is somewhat more complicated with a maximum rate (velocity, Vm) and a
Michaelis constant (Km) and the amount or concentration remaining.
The full differential equation for any component of a pharmacokinetic model can be constructed by adding an
equation segment for each arrow in the pharmacokinetic model.
The rules for each segment:
1- Direction of the arrow
*If the arrow goes into the component the equation segment is positive
*If the arrow leaves the component the equation segment is negative.
Introduction
Dr/Omnia Sarhan 10
2- Type of rate process
*If the rate process is first order multiply the (first order) rate constant by the amount or
concentration of drug in the component at the tail of the arrow.
*If the process is zero order just enter the rate constant.
Introduction
Dr/Omnia Sarhan 11
Component 1 There is one arrow leading out of component one so the rate process is negative.
This process is zero order so we just write the rate constant. The equation for this component is:
Component 2 This component is more of a challenge. There are three arrows connected with this
component. One arrow leads to the compartment so this equation segment is positive. The other
two arrows lead away from the component and these equation segments are negative. Starting
with the zero order process provides is a positive k0 to the differential equation. The first order
process is developed as the rate constant multiplied by the amount remaining in component 2.
This is negative and is -k1  X2. The final segment is the Michaelis Menten process from
component 2 to component 4. This is also negative and is described as -Vm x X2 / (Km + X2).
The total differential equation for this component is:
Introduction
Dr/Omnia Sarhan 12
Component 3 OK; downhill from here. Now we have one arrow going to this component from
component 2, thus the equation segment is positive. The rate process is first order so we multiply the
rate constant by the amount remaining in the component at the tail of the arrow, component 2. The
equation is:
Component 4 The fourth component is also described with one equation segment. The arrow leads to
this component so the segment is positive. The rate process is a Michaelis Menten process. The
equation for this component is:
Introduction
Dr/Omnia Sarhan 13
GRAPHS
Graphs are usually used to present the relationship between two or more variables. In pharmacokinetics, graphs
are commonly utilized to represent the drug concentration in the systemic circulation or drug pharmacological effect as
a function of time after drug administration. In the two-dimensional graphs that are commonly used in
pharmacokinetics, the drug concentration or drug effect (the dependent variable) is plotted on the y-axis, while time
(the independent variable) is plotted on the x-axis. There are two types of scales that are commonly utilized in
pharmacokinetics, the Cartesian scale and the semilog scale.
1- Cartesian Scale
In the Cartesian scale, both the y-axis and the x-axis are linear. Each point can be plotted on the Cartesian scale by
a pair of numerical coordinates that determine the perpendicular distance of the point from the x-axis and the y-axis.
Introduction
Dr/Omnia Sarhan 14
Although negative or positive values can be used for the coordinates in the
Cartesian scale, only positive coordinate values are used to present plasma
concentration versus time profile. The opposite Figure is an example of the
Cartesian scale.
2- Semilog Scale
The semilog scale has a logarithmic scale on the y-axis and a linear scale on
the x-axis, as in the next Figure. This type of graph is useful in plotting values
that are changing exponentially. On the semilog graph the spacing of the scale on
the y-axis is proportional to the logarithm of the number, not the number itself.
Plotting data on the semilog scale is equivalent of converting the dependent
variable values to their
Introduction
Dr/Omnia Sarhan 15
log values, and plotting the data on the
linear scale. The semilog graph paper
consists of repeated units called cycles.
Each of these cycles covers a single log10
unit, or 10-fold increase in number. The
semilog graph paper is available in one,
two, three, or more cycles per sheet.
Example
Plot the following drug concentration–
time data on the semilog scale:
Introduction
Dr/Omnia Sarhan 16
Answer
• The scale on the x-axis is chosen to make the time
points cover the largest portion of the x-axis.
• The drug concentration values are used to determine the
number of cycles needed.
Three cycles are needed to plot these values.
Problems
Dr/Omnia Sarhan 17
1-The linear relationship that describes the change in the drug amount (A) in mg, as a
function of time (t) in h, can be described by the following equation: A = 120 mg − 2
(mg/h) t.
a. Calculate the amount of the drug remaining after 10 h.
b. What is the time required for the drug amount to decrease to zero?
Problems
Dr/Omnia Sarhan
18
2- In an experiment to study the chemical decomposition, a drug solution was prepared and an aliquot of the
drug solution was obtained at different time points. The drug concentrations in the samples and the results
were as follows:
a. Draw the drug concentration against time on the Cartesian scale and graphically estimate the slope and y-
intercept.
b. Write the equation that describes the change in drug concentration with time.
Introduction
19
Rates and order of reactions
Rates
Is the velocity within which the reaction occurs. Consider the following reaction:
Drug A drug B
The amount of drug A is decreasing with respect to time
So Rate = - dA / dt (forward reaction)
Or
since the amount of B increases with respect to time
Rate = + dB / dt
The order of a reaction
Refers to the actual manner in which the concentration of the drug tends to influence the rate of
reaction or process. If the drug A changed to B and the concentration of A is C, the rate of change of A
to B as a function of time will expressed as
Dr/Omnia Sarhan
a +ve rate means that the concen. is increasing with time
(product).
a -ve rate means that the concentration is falling with time
(reactant).
Dr/ Omnia Sarhan
Introduction
21
dC / dt = - K Cn
Where;
dC / dt = the rate of reaction
K = rate constant
n = the order of the reaction or process.
When n = zero, it is called zero order reaction, when n = 1, it is called first order reaction, and so on.
1- Zero order kinetics (constant rate process);
Constant rate change and the change is independent on the concentration of the drug. It is not
possible to increase the rate of process by increasing the concentration of the drug. An example is the
elimination of alcohol. Drugs that show this type of elimination will show accumulation of plasma
levels of the drug and hence nonlinear pharmacokinetics.
Dr/Omnia Sarhan
Introduction
22
The amount of the drug (A) is decreasing at a constant time interval (t)
A = - Ko t + Ao
Where Ao = the amount of the drug at time = zero
A = the amount of the drug at time = t
Dr/Omnia Sarhan
Zero-Order Reaction
Graphically on cartesian paper:
t
k
C
Ct 0
0 

23
Time
Ct
C0
Slope=-k0
t
k
C
Ct 0
0 

Dr/Omnia Sarhan
– Equation of straight line:
– y = ax + b
– (a: slope, b: intercept)
x
y
Intercept
= b
Slope = a
kt
C
Ct 
 0
24
Dr/Omnia Sarhan
Introduction
25
The half-life (t ½);
Expresses the period of time required for the amount or concentration of a drug to decrease by one
half. Or the time required for the plasma concentration to drop from its initial value to the half. i.e.,
when t = t ½ , A = Ao / 2 .
t ½ for zero order reaction;
A = - Ko t + Ao
When t = t ½, A = Ao / 2
t ½ = Ao / 2 Ko
e.g., for zero order delivery
1. Sustained release
2. I.V infusion
3. Trans-dermal preparations
Dr/Omnia Sarhan
Half-life of Zero-order Reactions
0
0
2
/
1
2k
C
t 
t
k
C
Ct 0
0 

When one half-life has elapsed, by definition
2
/
1
0
0
0
2
t
k
C
C


2
0
C
Ct 
2
0
0
2
/
1
0
C
C
t
k 

2
0
2
/
1
0
C
t
k 
Dr/ Omnia Sarhan
0
0
2
/
1
2k
C
t 
– Half life of zero order reaction is directly proportional to
initial concentration.
– Thus half life decrease as reaction proceed with time
(when C0 is reduced by a factor of 2, the half-life is also
decreased by a factor of 2 (in fact each successive half-
life is half the preceding one)
100%A
10 min
50%A 25%A 12.5%A
5 min 2.5 min
27
Dr/Omnia Sarhan
Expiration Date
It is the date at which 10% drug concentration is decomposed
(increase toxicity & decrease activity).
k
C
t
10
0
90 
%
90
0
0
9
.
0 t
k
C
C 

0
9
.
0 C
Ct 
0
0
%
90 9
.
0 C
C
kt 
 0
90 1
.
0 C
t
k 
Dr/ Omnia Sarhan
A drug product has an initial concentration of 125 mg/ml decays by
zero order kinetics, (k=0.5 mg/ml/hr). What is the concentration of the
intact drug remaining after 3 days? When the drug reaches zero
concentration?
Answer:
C = Co – Kt
C = 125 - 0.5 * (3 x 24)
C = 89 mg / ml
C = Co – Kt
0 = 125 – 0.5*t
t = 250 hour
Example 1
29
Dr/Omnia Sarhan
t
C
C
k t
o 

1
.
/
00052
.
473
0.225
-
0.47
k 


 days
liter
mole
months
days
K
C
t o
15
452
00052
.
0
2
47
.
0
2
2
/
1 




The decomposition of multi-sulfa compound was found to follow zero order
kinetics. If its concentration was 0.47 mole/liter, when freshly prepared, and
after 473 days its concentration reached 0.225 mole/liter, calculate the
degradation rate constant and t1/2 .
Answer:
Example 2
kt
C
Ct 
 0
30
Dr/Omnia Sarhan
300 240
10
6
 
  
o t
C C
k
t

  
90%
0.1 0.1 300
3
10
o
C
t
K
The degradation of a drug product follows zero order process. If the
Concentration was 300 units/ml when freshly prepared & after 6
Months, its concentration reached 240 units/ml. Calculate the Constant
of reaction and the shelf life of the product.
Answer:
units/ml/month
months
Example 3
kt
C
Ct 
 0
Dr/ Omnia Sarhan
Introduction
32
2- First order kinetics (linear kinetics)
The rate of reaction is directly proportional to the concentration. i.e., the change depends on the
concentration.
ln A – ln Ao = - k t
ln (A/Ao) = - k t
A /Ao = e-Kt………….. (1)
Where e is the natural logarithm, the equation has one exponent and called monoexponential rate
process.
Since ln = 2.303 log, equation 1 can be written as;
Log A = log Ao – k t / 2.303 ............ (2)
A plot of log A versus time, a straight line is obtained whose
slope = k / 2.303
intercept = log Ao
Dr/Omnia Sarhan
Introduction
33
T½ for first order reaction
t ½ =0.693/ k
Dr/Omnia Sarhan
Graphically on
semilog paper
Co
1
2
1
2 log
log
t
t
y
y
slope



34
Dr/Omnia Sarhan
v
Conc.
Time
100
1
90
2
14
3
9
4
4.2
5
0.08
6
35
Dr/Omnia Sarhan
%
Remaining
Time
C0
Slope = -k/2.303
= (log y2 – log y1) / (x2 – x1)
No zero on y axis
36
Dr/Omnia Sarhan
k
t
693
.
0
2
/
1 
Half life t1/2 is constant
& doesn’t depend on
concentration.
2
log
303
.
2
2
/
1
k
t 
303
.
2
log
log 0
kt
C
Ct 

303
.
2
log
2
/
1
log 2
/
1
0
0
kt
C
C 

0
0
2
/
1
2
1
log
303
.
2
C
C
k
t 
0
0
2
/
1
2
/
1
log
log
303
.
2
C
C
kt


0
0
2
/
1
2
/
1
log
303
.
2 C
C
kt

37
Dr/Omnia Sarhan
100%A
10
min
50%
A
25%
A
12.5%
A
10
min
10
min
Half life t1/2 is constant
& doesn’t depend on
concentration.
38
Dr/Omnia Sarhan
ln ln o
c c kt
  
 
 
ln ln5 0.0005 120
ln 1.549 ln
4.71 /
C
C shift
C mg ml
  


90%
0.105 0.105
210
0.0005
t
k
  
Don’t forget to
check the units of
the problem
An ophthalmic solution dispensed at 5 mg/ml conc. exhibits a first order
reaction, with a rate constant of 0.0005 day-1. How much drug remaining
after 120 days? & how long will it take for the drug to degrade to 90% of its
initial concentration?
Answer:
A first order reaction
days
Example 1
39
Dr/Omnia Sarhan
The original concentration of one sample was 50 mg/ml. When assayed
20 months later the concentration was found to be 40 mg/ml, assuming
that the decomposition is first order, What is the half-life of this
product?
Ans.:
Co= 50mg/mL Ct= 40mg/mL t= 20 mon.
log Ct= log Co- Kt/2.303
log 40= log 50- 20K/2.303
K= 0.0111mon-1
T1/2= 0.693/K= 0.693/ 0.0111= 62.43 mon.
Example 2
40
Dr/Omnia Sarhan
1/ 2
0.693 0.693
0.1215
5.7
k
t
  
At 25 °C, the half-life period for the decomposition of N205 is 5.7
hours and is independent of the initial pressure of N205,
calculate:
a- The time for the completion of the reaction.
b- The specific rate constant for the reaction.
Answer:
•t1/2 is independent on the initial conc. So, it is 1st order, hence the
reaction never goes to an end and the life time (time for completion
of the reaction) is infinity.
hr-1
Example 3
41
Dr/Omnia Sarhan
Intercept
Slope
(x-
axis)
(y-axis)
Half-life
eqn.
Integrated
rate eqn.
Orde
r
Co
-Ko
t
C
t1/2 = Co
2k
Co – C = kt
0
Log Co
-K
2.303
t
LogC
t1/2 = 0.693
k
1
303
.
2
log
log 0
kt
C
Ct 

Dr/Omnia Sarhan
Dr/Omnia Sarhan 43

More Related Content

Similar to kinetics (Lec 1).pptx

Basic Pharmacokinetics & Compartments Modelling.pdf
Basic Pharmacokinetics & Compartments Modelling.pdfBasic Pharmacokinetics & Compartments Modelling.pdf
Basic Pharmacokinetics & Compartments Modelling.pdf
Ashwin Saxena
 
Strategies of linear feedback control and its classification
Strategies of linear feedback control and its classificationStrategies of linear feedback control and its classification
Strategies of linear feedback control and its classification
TELKOMNIKA JOURNAL
 
Concept of nonlinear pharmacokinetic
Concept of nonlinear pharmacokineticConcept of nonlinear pharmacokinetic
Concept of nonlinear pharmacokinetic
kavita bahmani
 
Math fundamentals
Math fundamentalsMath fundamentals
Math fundamentals
Areej Abu Hanieh
 
Basic concepts of pharmacokinetics
Basic concepts of pharmacokineticsBasic concepts of pharmacokinetics
Basic concepts of pharmacokinetics
Anand Addagalla
 
Basic concepts of pharmacokinetics
Basic concepts of pharmacokineticsBasic concepts of pharmacokinetics
Basic concepts of pharmacokinetics
Anand Addagalla
 
A seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationA seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationMalla Reddy College of Pharmacy
 
PK. introduction.ppt
PK. introduction.pptPK. introduction.ppt
PK. introduction.ppt
AsmaaRadwan6
 
1.pharmacokinetics
1.pharmacokinetics1.pharmacokinetics
1.pharmacokinetics
PNMallikarjun
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
RamDBawankar1
 
33151-33161.ppt
33151-33161.ppt33151-33161.ppt
33151-33161.ppt
dawitg2
 
METHOD OF RESIDUALS
METHOD OF RESIDUALSMETHOD OF RESIDUALS
METHOD OF RESIDUALS
Divya Pushp
 
Non linear pharmacokinetics
Non linear pharmacokineticsNon linear pharmacokinetics
Non linear pharmacokinetics
Shashi Yadav
 
Comparision of dissolution profile
Comparision of dissolution profileComparision of dissolution profile
Comparision of dissolution profileRanjith Karanam
 
Pharmacokinetics basics Introduced and applications
Pharmacokinetics basics Introduced  and applicationsPharmacokinetics basics Introduced  and applications
Pharmacokinetics basics Introduced and applications
Sumant Saini
 
Onecompartmentmodeling
OnecompartmentmodelingOnecompartmentmodeling
Onecompartmentmodeling
samyuktha metta
 
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciencesTherapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
khalafpharm
 
Pharmacokinetic and pharmacodynamic correlation
Pharmacokinetic and pharmacodynamic correlationPharmacokinetic and pharmacodynamic correlation
Pharmacokinetic and pharmacodynamic correlation
Dr. Ramesh Bhandari
 
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELSPHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
DollySadrani
 

Similar to kinetics (Lec 1).pptx (20)

Basic Pharmacokinetics & Compartments Modelling.pdf
Basic Pharmacokinetics & Compartments Modelling.pdfBasic Pharmacokinetics & Compartments Modelling.pdf
Basic Pharmacokinetics & Compartments Modelling.pdf
 
Strategies of linear feedback control and its classification
Strategies of linear feedback control and its classificationStrategies of linear feedback control and its classification
Strategies of linear feedback control and its classification
 
Concept of nonlinear pharmacokinetic
Concept of nonlinear pharmacokineticConcept of nonlinear pharmacokinetic
Concept of nonlinear pharmacokinetic
 
Math fundamentals
Math fundamentalsMath fundamentals
Math fundamentals
 
Basic concepts of pharmacokinetics
Basic concepts of pharmacokineticsBasic concepts of pharmacokinetics
Basic concepts of pharmacokinetics
 
Basic concepts of pharmacokinetics
Basic concepts of pharmacokineticsBasic concepts of pharmacokinetics
Basic concepts of pharmacokinetics
 
A seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationA seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administration
 
PK. introduction.ppt
PK. introduction.pptPK. introduction.ppt
PK. introduction.ppt
 
1.pharmacokinetics
1.pharmacokinetics1.pharmacokinetics
1.pharmacokinetics
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
33151-33161.ppt
33151-33161.ppt33151-33161.ppt
33151-33161.ppt
 
METHOD OF RESIDUALS
METHOD OF RESIDUALSMETHOD OF RESIDUALS
METHOD OF RESIDUALS
 
Non linear pharmacokinetics
Non linear pharmacokineticsNon linear pharmacokinetics
Non linear pharmacokinetics
 
Nonlinear Pharmacokinetics
Nonlinear PharmacokineticsNonlinear Pharmacokinetics
Nonlinear Pharmacokinetics
 
Comparision of dissolution profile
Comparision of dissolution profileComparision of dissolution profile
Comparision of dissolution profile
 
Pharmacokinetics basics Introduced and applications
Pharmacokinetics basics Introduced  and applicationsPharmacokinetics basics Introduced  and applications
Pharmacokinetics basics Introduced and applications
 
Onecompartmentmodeling
OnecompartmentmodelingOnecompartmentmodeling
Onecompartmentmodeling
 
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciencesTherapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
 
Pharmacokinetic and pharmacodynamic correlation
Pharmacokinetic and pharmacodynamic correlationPharmacokinetic and pharmacodynamic correlation
Pharmacokinetic and pharmacodynamic correlation
 
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELSPHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
 

More from HebaYassin10

Pharmaceutics-I-DOSAGE-FORM.ppt
Pharmaceutics-I-DOSAGE-FORM.pptPharmaceutics-I-DOSAGE-FORM.ppt
Pharmaceutics-I-DOSAGE-FORM.ppt
HebaYassin10
 
lecture 2 (1).pptx
lecture 2 (1).pptxlecture 2 (1).pptx
lecture 2 (1).pptx
HebaYassin10
 
tablets_part_1.pdf
tablets_part_1.pdftablets_part_1.pdf
tablets_part_1.pdf
HebaYassin10
 
states_of_matter.ppt
states_of_matter.pptstates_of_matter.ppt
states_of_matter.ppt
HebaYassin10
 
pharmaceuticalcreams-151214135634.pdf
pharmaceuticalcreams-151214135634.pdfpharmaceuticalcreams-151214135634.pdf
pharmaceuticalcreams-151214135634.pdf
HebaYassin10
 
creamsandgels-191212173159.pdf
creamsandgels-191212173159.pdfcreamsandgels-191212173159.pdf
creamsandgels-191212173159.pdf
HebaYassin10
 
cream-170204113026.pdf
cream-170204113026.pdfcream-170204113026.pdf
cream-170204113026.pdf
HebaYassin10
 
Office hours, Dosge form II.docx
Office hours, Dosge form II.docxOffice hours, Dosge form II.docx
Office hours, Dosge form II.docx
HebaYassin10
 
Lecture 7 cream.pptx
Lecture 7 cream.pptxLecture 7 cream.pptx
Lecture 7 cream.pptx
HebaYassin10
 
liquid dosage form.pptx
liquid dosage form.pptxliquid dosage form.pptx
liquid dosage form.pptx
HebaYassin10
 
شريحة الرؤية والرسالة.ppt
شريحة الرؤية والرسالة.pptشريحة الرؤية والرسالة.ppt
شريحة الرؤية والرسالة.ppt
HebaYassin10
 
Menstrual -Intestinal gas discomfort - lactose-Practice-2018.pptx
Menstrual -Intestinal gas discomfort - lactose-Practice-2018.pptxMenstrual -Intestinal gas discomfort - lactose-Practice-2018.pptx
Menstrual -Intestinal gas discomfort - lactose-Practice-2018.pptx
HebaYassin10
 
Lecture 4.ppt
Lecture 4.pptLecture 4.ppt
Lecture 4.ppt
HebaYassin10
 
biopharmaceutics - Copy (2).ppt
biopharmaceutics - Copy (2).pptbiopharmaceutics - Copy (2).ppt
biopharmaceutics - Copy (2).ppt
HebaYassin10
 
lecture 2.ppt
lecture 2.pptlecture 2.ppt
lecture 2.ppt
HebaYassin10
 
مراحل وتشخيص الأزمة .pptx
مراحل وتشخيص الأزمة .pptxمراحل وتشخيص الأزمة .pptx
مراحل وتشخيص الأزمة .pptx
HebaYassin10
 
كيفية إدارة الأزمات 000.pptx
كيفية إدارة الأزمات 000.pptxكيفية إدارة الأزمات 000.pptx
كيفية إدارة الأزمات 000.pptx
HebaYassin10
 
Semisolid_Dosage_Forms_SCU_2016.pptx
Semisolid_Dosage_Forms_SCU_2016.pptxSemisolid_Dosage_Forms_SCU_2016.pptx
Semisolid_Dosage_Forms_SCU_2016.pptx
HebaYassin10
 
lecture 5.pdf
lecture 5.pdflecture 5.pdf
lecture 5.pdf
HebaYassin10
 
Surfactant lec 2.ppt
Surfactant lec 2.pptSurfactant lec 2.ppt
Surfactant lec 2.ppt
HebaYassin10
 

More from HebaYassin10 (20)

Pharmaceutics-I-DOSAGE-FORM.ppt
Pharmaceutics-I-DOSAGE-FORM.pptPharmaceutics-I-DOSAGE-FORM.ppt
Pharmaceutics-I-DOSAGE-FORM.ppt
 
lecture 2 (1).pptx
lecture 2 (1).pptxlecture 2 (1).pptx
lecture 2 (1).pptx
 
tablets_part_1.pdf
tablets_part_1.pdftablets_part_1.pdf
tablets_part_1.pdf
 
states_of_matter.ppt
states_of_matter.pptstates_of_matter.ppt
states_of_matter.ppt
 
pharmaceuticalcreams-151214135634.pdf
pharmaceuticalcreams-151214135634.pdfpharmaceuticalcreams-151214135634.pdf
pharmaceuticalcreams-151214135634.pdf
 
creamsandgels-191212173159.pdf
creamsandgels-191212173159.pdfcreamsandgels-191212173159.pdf
creamsandgels-191212173159.pdf
 
cream-170204113026.pdf
cream-170204113026.pdfcream-170204113026.pdf
cream-170204113026.pdf
 
Office hours, Dosge form II.docx
Office hours, Dosge form II.docxOffice hours, Dosge form II.docx
Office hours, Dosge form II.docx
 
Lecture 7 cream.pptx
Lecture 7 cream.pptxLecture 7 cream.pptx
Lecture 7 cream.pptx
 
liquid dosage form.pptx
liquid dosage form.pptxliquid dosage form.pptx
liquid dosage form.pptx
 
شريحة الرؤية والرسالة.ppt
شريحة الرؤية والرسالة.pptشريحة الرؤية والرسالة.ppt
شريحة الرؤية والرسالة.ppt
 
Menstrual -Intestinal gas discomfort - lactose-Practice-2018.pptx
Menstrual -Intestinal gas discomfort - lactose-Practice-2018.pptxMenstrual -Intestinal gas discomfort - lactose-Practice-2018.pptx
Menstrual -Intestinal gas discomfort - lactose-Practice-2018.pptx
 
Lecture 4.ppt
Lecture 4.pptLecture 4.ppt
Lecture 4.ppt
 
biopharmaceutics - Copy (2).ppt
biopharmaceutics - Copy (2).pptbiopharmaceutics - Copy (2).ppt
biopharmaceutics - Copy (2).ppt
 
lecture 2.ppt
lecture 2.pptlecture 2.ppt
lecture 2.ppt
 
مراحل وتشخيص الأزمة .pptx
مراحل وتشخيص الأزمة .pptxمراحل وتشخيص الأزمة .pptx
مراحل وتشخيص الأزمة .pptx
 
كيفية إدارة الأزمات 000.pptx
كيفية إدارة الأزمات 000.pptxكيفية إدارة الأزمات 000.pptx
كيفية إدارة الأزمات 000.pptx
 
Semisolid_Dosage_Forms_SCU_2016.pptx
Semisolid_Dosage_Forms_SCU_2016.pptxSemisolid_Dosage_Forms_SCU_2016.pptx
Semisolid_Dosage_Forms_SCU_2016.pptx
 
lecture 5.pdf
lecture 5.pdflecture 5.pdf
lecture 5.pdf
 
Surfactant lec 2.ppt
Surfactant lec 2.pptSurfactant lec 2.ppt
Surfactant lec 2.ppt
 

Recently uploaded

ESR spectroscopy in liquid food and beverages.pptx
ESR spectroscopy in liquid food and beverages.pptxESR spectroscopy in liquid food and beverages.pptx
ESR spectroscopy in liquid food and beverages.pptx
PRIYANKA PATEL
 
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
Abdul Wali Khan University Mardan,kP,Pakistan
 
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityDeep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
University of Rennes, INSA Rennes, Inria/IRISA, CNRS
 
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdfDMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
fafyfskhan251kmf
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
moosaasad1975
 
Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
RenuJangid3
 
Eukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptxEukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptx
RitabrataSarkar3
 
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
David Osipyan
 
Phenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvementPhenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvement
IshaGoswami9
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
Oedema_types_causes_pathophysiology.pptx
Oedema_types_causes_pathophysiology.pptxOedema_types_causes_pathophysiology.pptx
Oedema_types_causes_pathophysiology.pptx
muralinath2
 
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
yqqaatn0
 
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốtmô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
HongcNguyn6
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
tonzsalvador2222
 
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxThe use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
MAGOTI ERNEST
 
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptxANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
RASHMI M G
 
Shallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptxShallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptx
Gokturk Mehmet Dilci
 
NuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyerNuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyer
pablovgd
 
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
yqqaatn0
 
BREEDING METHODS FOR DISEASE RESISTANCE.pptx
BREEDING METHODS FOR DISEASE RESISTANCE.pptxBREEDING METHODS FOR DISEASE RESISTANCE.pptx
BREEDING METHODS FOR DISEASE RESISTANCE.pptx
RASHMI M G
 

Recently uploaded (20)

ESR spectroscopy in liquid food and beverages.pptx
ESR spectroscopy in liquid food and beverages.pptxESR spectroscopy in liquid food and beverages.pptx
ESR spectroscopy in liquid food and beverages.pptx
 
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
 
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityDeep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
 
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdfDMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
 
Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
 
Eukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptxEukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptx
 
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
 
Phenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvementPhenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvement
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
Oedema_types_causes_pathophysiology.pptx
Oedema_types_causes_pathophysiology.pptxOedema_types_causes_pathophysiology.pptx
Oedema_types_causes_pathophysiology.pptx
 
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
 
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốtmô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
 
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxThe use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
 
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptxANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
 
Shallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptxShallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptx
 
NuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyerNuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyer
 
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
 
BREEDING METHODS FOR DISEASE RESISTANCE.pptx
BREEDING METHODS FOR DISEASE RESISTANCE.pptxBREEDING METHODS FOR DISEASE RESISTANCE.pptx
BREEDING METHODS FOR DISEASE RESISTANCE.pptx
 

kinetics (Lec 1).pptx

  • 2. Dr/Omnia Sarhan ‫الكليـــــــــــــة‬ ‫رؤيــــــــــــة‬ ‫الكليــــــــــــة‬ ‫رســـــــــــــــالة‬ ‫الريادة‬ ً ‫محليا‬ ً ‫واقليميا‬ ً ‫ودوليا‬ ‫لالرتقاء‬ ‫بصحة‬ ‫االنسان‬ ‫من‬ ‫خالل‬ ‫استخدا‬ ‫م‬ ‫االبتكارات‬ ‫فى‬ ‫مجال‬ ‫التعليم‬ ‫والبحوث‬ ‫العلمية‬ ‫والممارسات‬ ‫التطبيقية‬ . ‫توفير‬ ‫أفضل‬ ‫الممارسات‬ ‫في‬ ‫مجال‬ ‫التعليم‬ ‫والتعلم‬ ‫والتدريب‬ ‫وإستمرارية‬ ‫خ‬ ‫لق‬ ‫فرص‬ ‫للطالب‬ ‫والخريجين‬ ‫بإبتكار‬ ‫ونشر‬ ‫وتطبيق‬ ‫المعرفة‬ ‫الحديثة‬ ‫المرتكزة‬ ‫على‬ ‫البحوث‬ ‫والتطبيقات‬ ‫في‬ ‫العلوم‬ ‫الصيدلية‬ ‫واإلكلينيكية‬ ‫واإلجتماعية‬ ‫للنهوض‬ ‫بال‬ ‫صحة‬
  • 3. Dr/Omnia Sarhan 3 Upon successful completion of this course the student should be able to; • Describe the physicochemical and physiological factors that influence the absorption of drugs from extra and intravascular routs of administration, their distribution within the body, and their routes and mechanisms of elimination • Explain how dose, bioavailability, rate of absorption, apparent volume of distribution, total clearance, and elimination half-life affect the plasma concentrations of a drug after administration of single oral or single IV bolus dose • Describe the factors which determine the time-course of systemic accumulation of a drug administered by multiple oral, multiple IV bolus and continuous infusion doses • Differentiate between linear and non-linear pharmacokinetic models
  • 4. Introduction Dr/Omnia Sarhan 4 I- Logarithm The logarithm of a number is the exponent or power to which a given base number must be raised to equal that number. Thus, the logarithm of Y to the base, b, equals X, or log b (Y) = X. The logarithm of 0 and all negative numbers is undefined or nonexistent. The logarithm of 1 is 0 and of numbers <1 is negative in all systems. The relationships between common and natural logarithms are the following: a. log Y = ln Y/ln 10 = ln Y/2.303 b. ln Y = ln 10 × log Y = 2.303 × log Y
  • 5. Introduction Dr/Omnia Sarhan 5 II- Calculus 1- Differential Calculus Pharmacokinetics is the study of the rate of drug absorption and disposition in the body. Thus differential calculus is an important stepping stone in the development of many of the equations used. Differential calculus is involved with the study of rates of processes. The calculus part comes in when we look at these processes in detail, that is, during small time intervals. We may say that at time zero a patient has a concentration of 25 mg/l of a drug in plasma and at time 24 hours the concentration is 5 mg/l. That may be interesting in itself, but it doesn't give us any idea of the concentration between 0 and 24 hours, or after 24 hours. Using differential calculus we are able to develop equations to look at the process during the small time intervals that make up the total time interval of 0 to 24 hours.
  • 6. Introduction Dr/Omnia Sarhan 6 In many cases the rate of elimination of a drug can be described as being dependent on or proportional to the amount of drug remaining to be eliminated. That is, the process obeys first order kinetics. This can illustrated by the opposite Figure. This can be described mathematically using equation: Where: k is a proportionality constant (rate constant) X is the amount remaining to be eliminated.
  • 7. Introduction Dr/Omnia Sarhan 7 Note: the use of the symbol 'd' to represent a very small increment in X or t. Thus dX/dt represents the slope of the line (or rate of change) over a small region of the curved line. When data are collected at discrete times such as 4 and 6 hours the larger change in X and t can be represented by ΔX/Δt Integration of the above equation (and other differential equations) provides the following integrated equations: 2- Integral Calculus Differentiation is the reverse of integration. With differentiation breaking a process down to look at the instantaneous process, integration sums up the information from small time intervals to give a total result over a larger time period.
  • 8. Introduction Dr/Omnia Sarhan 8 First: How writing differential equations? Rate processes in the field of pharmacokinetics are usually limited to first order, zero order and occasionally Michaelis-Menten kinetics. Linear pharmacokinetic systems consist of first order disposition processes and bolus doses, first order or zero order absorption rate processes. These rate processes can be described mathematically. First Order Equation Each first order rate process is described by a first order rate constant (k1) and the amount or concentration remaining to be transferred (X1). Zero Order Equation
  • 9. Introduction Dr/Omnia Sarhan 9 Zero order rate processes are described by the rate constant alone. Michaelis Menten Equation The Michaelis Menten process is somewhat more complicated with a maximum rate (velocity, Vm) and a Michaelis constant (Km) and the amount or concentration remaining. The full differential equation for any component of a pharmacokinetic model can be constructed by adding an equation segment for each arrow in the pharmacokinetic model. The rules for each segment: 1- Direction of the arrow *If the arrow goes into the component the equation segment is positive *If the arrow leaves the component the equation segment is negative.
  • 10. Introduction Dr/Omnia Sarhan 10 2- Type of rate process *If the rate process is first order multiply the (first order) rate constant by the amount or concentration of drug in the component at the tail of the arrow. *If the process is zero order just enter the rate constant.
  • 11. Introduction Dr/Omnia Sarhan 11 Component 1 There is one arrow leading out of component one so the rate process is negative. This process is zero order so we just write the rate constant. The equation for this component is: Component 2 This component is more of a challenge. There are three arrows connected with this component. One arrow leads to the compartment so this equation segment is positive. The other two arrows lead away from the component and these equation segments are negative. Starting with the zero order process provides is a positive k0 to the differential equation. The first order process is developed as the rate constant multiplied by the amount remaining in component 2. This is negative and is -k1  X2. The final segment is the Michaelis Menten process from component 2 to component 4. This is also negative and is described as -Vm x X2 / (Km + X2). The total differential equation for this component is:
  • 12. Introduction Dr/Omnia Sarhan 12 Component 3 OK; downhill from here. Now we have one arrow going to this component from component 2, thus the equation segment is positive. The rate process is first order so we multiply the rate constant by the amount remaining in the component at the tail of the arrow, component 2. The equation is: Component 4 The fourth component is also described with one equation segment. The arrow leads to this component so the segment is positive. The rate process is a Michaelis Menten process. The equation for this component is:
  • 13. Introduction Dr/Omnia Sarhan 13 GRAPHS Graphs are usually used to present the relationship between two or more variables. In pharmacokinetics, graphs are commonly utilized to represent the drug concentration in the systemic circulation or drug pharmacological effect as a function of time after drug administration. In the two-dimensional graphs that are commonly used in pharmacokinetics, the drug concentration or drug effect (the dependent variable) is plotted on the y-axis, while time (the independent variable) is plotted on the x-axis. There are two types of scales that are commonly utilized in pharmacokinetics, the Cartesian scale and the semilog scale. 1- Cartesian Scale In the Cartesian scale, both the y-axis and the x-axis are linear. Each point can be plotted on the Cartesian scale by a pair of numerical coordinates that determine the perpendicular distance of the point from the x-axis and the y-axis.
  • 14. Introduction Dr/Omnia Sarhan 14 Although negative or positive values can be used for the coordinates in the Cartesian scale, only positive coordinate values are used to present plasma concentration versus time profile. The opposite Figure is an example of the Cartesian scale. 2- Semilog Scale The semilog scale has a logarithmic scale on the y-axis and a linear scale on the x-axis, as in the next Figure. This type of graph is useful in plotting values that are changing exponentially. On the semilog graph the spacing of the scale on the y-axis is proportional to the logarithm of the number, not the number itself. Plotting data on the semilog scale is equivalent of converting the dependent variable values to their
  • 15. Introduction Dr/Omnia Sarhan 15 log values, and plotting the data on the linear scale. The semilog graph paper consists of repeated units called cycles. Each of these cycles covers a single log10 unit, or 10-fold increase in number. The semilog graph paper is available in one, two, three, or more cycles per sheet. Example Plot the following drug concentration– time data on the semilog scale:
  • 16. Introduction Dr/Omnia Sarhan 16 Answer • The scale on the x-axis is chosen to make the time points cover the largest portion of the x-axis. • The drug concentration values are used to determine the number of cycles needed. Three cycles are needed to plot these values.
  • 17. Problems Dr/Omnia Sarhan 17 1-The linear relationship that describes the change in the drug amount (A) in mg, as a function of time (t) in h, can be described by the following equation: A = 120 mg − 2 (mg/h) t. a. Calculate the amount of the drug remaining after 10 h. b. What is the time required for the drug amount to decrease to zero?
  • 18. Problems Dr/Omnia Sarhan 18 2- In an experiment to study the chemical decomposition, a drug solution was prepared and an aliquot of the drug solution was obtained at different time points. The drug concentrations in the samples and the results were as follows: a. Draw the drug concentration against time on the Cartesian scale and graphically estimate the slope and y- intercept. b. Write the equation that describes the change in drug concentration with time.
  • 19. Introduction 19 Rates and order of reactions Rates Is the velocity within which the reaction occurs. Consider the following reaction: Drug A drug B The amount of drug A is decreasing with respect to time So Rate = - dA / dt (forward reaction) Or since the amount of B increases with respect to time Rate = + dB / dt The order of a reaction Refers to the actual manner in which the concentration of the drug tends to influence the rate of reaction or process. If the drug A changed to B and the concentration of A is C, the rate of change of A to B as a function of time will expressed as Dr/Omnia Sarhan
  • 20. a +ve rate means that the concen. is increasing with time (product). a -ve rate means that the concentration is falling with time (reactant). Dr/ Omnia Sarhan
  • 21. Introduction 21 dC / dt = - K Cn Where; dC / dt = the rate of reaction K = rate constant n = the order of the reaction or process. When n = zero, it is called zero order reaction, when n = 1, it is called first order reaction, and so on. 1- Zero order kinetics (constant rate process); Constant rate change and the change is independent on the concentration of the drug. It is not possible to increase the rate of process by increasing the concentration of the drug. An example is the elimination of alcohol. Drugs that show this type of elimination will show accumulation of plasma levels of the drug and hence nonlinear pharmacokinetics. Dr/Omnia Sarhan
  • 22. Introduction 22 The amount of the drug (A) is decreasing at a constant time interval (t) A = - Ko t + Ao Where Ao = the amount of the drug at time = zero A = the amount of the drug at time = t Dr/Omnia Sarhan
  • 23. Zero-Order Reaction Graphically on cartesian paper: t k C Ct 0 0   23 Time Ct C0 Slope=-k0 t k C Ct 0 0   Dr/Omnia Sarhan
  • 24. – Equation of straight line: – y = ax + b – (a: slope, b: intercept) x y Intercept = b Slope = a kt C Ct   0 24 Dr/Omnia Sarhan
  • 25. Introduction 25 The half-life (t ½); Expresses the period of time required for the amount or concentration of a drug to decrease by one half. Or the time required for the plasma concentration to drop from its initial value to the half. i.e., when t = t ½ , A = Ao / 2 . t ½ for zero order reaction; A = - Ko t + Ao When t = t ½, A = Ao / 2 t ½ = Ao / 2 Ko e.g., for zero order delivery 1. Sustained release 2. I.V infusion 3. Trans-dermal preparations Dr/Omnia Sarhan
  • 26. Half-life of Zero-order Reactions 0 0 2 / 1 2k C t  t k C Ct 0 0   When one half-life has elapsed, by definition 2 / 1 0 0 0 2 t k C C   2 0 C Ct  2 0 0 2 / 1 0 C C t k   2 0 2 / 1 0 C t k  Dr/ Omnia Sarhan
  • 27. 0 0 2 / 1 2k C t  – Half life of zero order reaction is directly proportional to initial concentration. – Thus half life decrease as reaction proceed with time (when C0 is reduced by a factor of 2, the half-life is also decreased by a factor of 2 (in fact each successive half- life is half the preceding one) 100%A 10 min 50%A 25%A 12.5%A 5 min 2.5 min 27 Dr/Omnia Sarhan
  • 28. Expiration Date It is the date at which 10% drug concentration is decomposed (increase toxicity & decrease activity). k C t 10 0 90  % 90 0 0 9 . 0 t k C C   0 9 . 0 C Ct  0 0 % 90 9 . 0 C C kt   0 90 1 . 0 C t k  Dr/ Omnia Sarhan
  • 29. A drug product has an initial concentration of 125 mg/ml decays by zero order kinetics, (k=0.5 mg/ml/hr). What is the concentration of the intact drug remaining after 3 days? When the drug reaches zero concentration? Answer: C = Co – Kt C = 125 - 0.5 * (3 x 24) C = 89 mg / ml C = Co – Kt 0 = 125 – 0.5*t t = 250 hour Example 1 29 Dr/Omnia Sarhan
  • 30. t C C k t o   1 . / 00052 . 473 0.225 - 0.47 k     days liter mole months days K C t o 15 452 00052 . 0 2 47 . 0 2 2 / 1      The decomposition of multi-sulfa compound was found to follow zero order kinetics. If its concentration was 0.47 mole/liter, when freshly prepared, and after 473 days its concentration reached 0.225 mole/liter, calculate the degradation rate constant and t1/2 . Answer: Example 2 kt C Ct   0 30 Dr/Omnia Sarhan
  • 31. 300 240 10 6      o t C C k t     90% 0.1 0.1 300 3 10 o C t K The degradation of a drug product follows zero order process. If the Concentration was 300 units/ml when freshly prepared & after 6 Months, its concentration reached 240 units/ml. Calculate the Constant of reaction and the shelf life of the product. Answer: units/ml/month months Example 3 kt C Ct   0 Dr/ Omnia Sarhan
  • 32. Introduction 32 2- First order kinetics (linear kinetics) The rate of reaction is directly proportional to the concentration. i.e., the change depends on the concentration. ln A – ln Ao = - k t ln (A/Ao) = - k t A /Ao = e-Kt………….. (1) Where e is the natural logarithm, the equation has one exponent and called monoexponential rate process. Since ln = 2.303 log, equation 1 can be written as; Log A = log Ao – k t / 2.303 ............ (2) A plot of log A versus time, a straight line is obtained whose slope = k / 2.303 intercept = log Ao Dr/Omnia Sarhan
  • 33. Introduction 33 T½ for first order reaction t ½ =0.693/ k Dr/Omnia Sarhan
  • 34. Graphically on semilog paper Co 1 2 1 2 log log t t y y slope    34 Dr/Omnia Sarhan
  • 36. % Remaining Time C0 Slope = -k/2.303 = (log y2 – log y1) / (x2 – x1) No zero on y axis 36 Dr/Omnia Sarhan
  • 37. k t 693 . 0 2 / 1  Half life t1/2 is constant & doesn’t depend on concentration. 2 log 303 . 2 2 / 1 k t  303 . 2 log log 0 kt C Ct   303 . 2 log 2 / 1 log 2 / 1 0 0 kt C C   0 0 2 / 1 2 1 log 303 . 2 C C k t  0 0 2 / 1 2 / 1 log log 303 . 2 C C kt   0 0 2 / 1 2 / 1 log 303 . 2 C C kt  37 Dr/Omnia Sarhan
  • 38. 100%A 10 min 50% A 25% A 12.5% A 10 min 10 min Half life t1/2 is constant & doesn’t depend on concentration. 38 Dr/Omnia Sarhan
  • 39. ln ln o c c kt        ln ln5 0.0005 120 ln 1.549 ln 4.71 / C C shift C mg ml      90% 0.105 0.105 210 0.0005 t k    Don’t forget to check the units of the problem An ophthalmic solution dispensed at 5 mg/ml conc. exhibits a first order reaction, with a rate constant of 0.0005 day-1. How much drug remaining after 120 days? & how long will it take for the drug to degrade to 90% of its initial concentration? Answer: A first order reaction days Example 1 39 Dr/Omnia Sarhan
  • 40. The original concentration of one sample was 50 mg/ml. When assayed 20 months later the concentration was found to be 40 mg/ml, assuming that the decomposition is first order, What is the half-life of this product? Ans.: Co= 50mg/mL Ct= 40mg/mL t= 20 mon. log Ct= log Co- Kt/2.303 log 40= log 50- 20K/2.303 K= 0.0111mon-1 T1/2= 0.693/K= 0.693/ 0.0111= 62.43 mon. Example 2 40 Dr/Omnia Sarhan
  • 41. 1/ 2 0.693 0.693 0.1215 5.7 k t    At 25 °C, the half-life period for the decomposition of N205 is 5.7 hours and is independent of the initial pressure of N205, calculate: a- The time for the completion of the reaction. b- The specific rate constant for the reaction. Answer: •t1/2 is independent on the initial conc. So, it is 1st order, hence the reaction never goes to an end and the life time (time for completion of the reaction) is infinity. hr-1 Example 3 41 Dr/Omnia Sarhan
  • 42. Intercept Slope (x- axis) (y-axis) Half-life eqn. Integrated rate eqn. Orde r Co -Ko t C t1/2 = Co 2k Co – C = kt 0 Log Co -K 2.303 t LogC t1/2 = 0.693 k 1 303 . 2 log log 0 kt C Ct   Dr/Omnia Sarhan